How many employees does Ubc Late Stage (UK) Limited have?

Ubc Late Stage (UK) Limited reported an average of 90 employees in the year to 31 Dec 2025.

Is Ubc Late Stage (UK) Limited profitable?

Yes — Ubc Late Stage (UK) Limited reported a profit of £497k in the year to 31 Dec 2025.

Company No. 06776534 · Incorporated 18 Dec 2008

Ubc Late Stage (UK) Limited

Registered name: UBC LATE STAGE (UK) LIMITED

Part of United Biosource Holding (UK) Limited group

Ubc Late Stage (UK) Limited made £497k profit in the year to 31 Dec 2025 (revenue not disclosed).

Ubc Late Stage (UK) Limited reported £497k profit in the year to 31 Dec 2025, up 8% on the year before; its revenue was not disclosed. It had 90 employees. The company is classified under “research and experimental development on biotechnology” and is based in London; we hold 4 years of its filed accounts.

Profit onlySection M · Professional, scientific and technical activitiesSIC 72110Research and experimental development on biotechnology

Status: Active
Location: London, London
Age: 17 yrs · since 2008
Type: Private Limited Company

Part of a group. The filing indicates this company sits within a group structure, so its results may depend on intra-group trading and it may be hard to replicate independently. From the filing: “The immediate parent company is United BioSource Holding (UK) Limited. Their registered address is 12 New Fetter Lane, London, EC4A 1JP.”

Latest accounts · year to 31 Dec 2025

Key figures

Revenue

—

Not disclosed in filing

Profit

£497k

Growth ▲7.8%

Profit margin

—

Employees

Change ▲4.7%

Profit / employee

£5.5k

Profitable streak

4yrs

Consecutive profitable years in our data

This company published its profit but not its turnover, so revenue and margins are not disclosed. We never estimate them.

Badges are automated estimates derived from the filed figures — not statements of fact about the company.

4 filed years

Financial history

Multi-year financials, oldest to newest
Year to	31 Dec 2022	31 Dec 2023	31 Dec 2024	31 Dec 2025
Disclosure	Profit only	Profit only	Profit only	Profit only
Profit & loss
Revenue (turnover)	—	—	—	—
Cost of sales	£6.8m	£7.8m	£10.3m	£12.4m
Profit before tax	£424k	£500k	£633k	£743k
Profit after tax	£304k	£332k	£461k	£497k
Profit (best available)	£304k	£332k	£461k	£497k
Staff costs	—	£7.3m	£9.2m	£11.2m
Employees (average)	58	73	86	90
Ratios
Profit margin	—	—	—	—
Profit per employee	£5.2k	£4.5k	£5.4k	£5.5k
Growth (year on year)
Profit growth	—	▲9.1%	▲38.9%	▲7.8%
Headcount growth	—	▲25.9%	▲17.8%	▲4.7%
Balance sheet — indirect signals, not revenue
Cash at bank	£107k	£124k	£178k	£260k
Net assets	£5m	£5.3m	£5.8m	£6.2m
Fixed assets	£438k	£449k	£417k	£325k
Current assets	£6.6m	£7.3m	£8.1m	£10.3m
Debtors	£66.5k	£320k	£237k	£45.8k
Deferred income	£751k	£1.1m	£1.8m	£2.7m
Source	FullAccounts · bulk data Oct 2024	FullAccounts · bulk data Oct 2024	FullAccounts · bulk data Aug 2025	FullAccounts · bulk data Sep 2026

Derived from the latest filing

How the business works

Profit margin: —; Profit ÷ revenue.
Gross margin: —; Gross profit ÷ revenue. High for software and services.
Revenue per employee: —; Revenue ÷ average employees.
Profit per employee: £5.5k; Profit ÷ average employees.
Cash conversion: —; Cash generated from operations ÷ operating profit. Needs a cash-flow statement.
Fixed assets ÷ revenue: —; Capital intensity. Low = capital-light, cheaper to start.
Deferred income ÷ revenue: —; Customers paying upfront (subscriptions, deposits). Approximate when combined with accruals.
Debtors ÷ revenue: —; Money owed by customers. Low = customers pay quickly.

Indirect — not revenue

Balance-sheet signals

Year-on-year changes in filed balance-sheet items. They can hint at momentum (or investment) but are not revenue or profit and must not be read as such.

Net assets: ▲9%; Now £6.2m
Cash at bank: ▲46%; Now £260k
Headcount: ▲5%; Now 90
Deferred income: ▲50%; Now £2.7m
Fixed assets: ▼22%; Now £325k

Deferred income is reported together with accruals in this filing (“accruals and deferred income”), so it is an approximate signal only.

Corporate ownership

Group structure

Ownership chain

United Biosource Holding (UK) Limitedultimate parent75–100%
Ubc Late Stage (UK) Limitedthis company

Bands show the share of ownership each company holds in the one below it.

From the Persons with Significant Control register (corporate controllers only).

Same industry, similar size

Similar profitable businesses

Industry benchmarks →

Sources

Companies House profile Filing history & original accounts

Latest figures from FullAccounts for the year to 31 Dec 2025 (profit £497k), from the Companies House accounts bulk data published Sep 2026. Spotted an error? Request a correction.

Contains public sector information from Companies House licensed under the Open Government Licence v3.0. Data from Companies House, © Crown copyright. View the licence.